Skip to main content

Table 1 Hematological and chemistry laboratory values

From: Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report

Parameter (reference range)

Admission (day 0)

Postplasmapheresis (day 5)

Initiation of eculizumab (6 weeks after)

WBC, 109/L

12

7.2

5.3

Hb, g/dl

9.1

8.2

8.0

Platelets, 109/L

150

219

202

Serum Na+, mEq/L

142

135

130

Serum K+, mEq/L

4.4

5.5

5.6

Serum bicarbonate, mEq/L

7

26

27

BUN, mg/dl

33

34

66

Creatinine, mg/dl

3.4

3.6

5.6

Glucose, mg/dl

520

–

–

Indirect bilirubin, mg/dl (0.2–0.8)

1.7

0.7

–

LDH, IU/L

1700

763

–

Haptoglobin, mg/dl (43–212)

<15

–

–

pH

7.33

–

–

Anion gap

20

–

–

β-Hydroxybutyrate, mmol/L (0.02–0.27)

1.21

–

–

ADAMTS13

81 %

–

–

Schistocytes

Present

None

–

Urinalysis

   

 pH

6.0

  

 Protein, mg/dl

>300

  

 Glucose, mg/dl

>1000

–

–

 RBC

25–30/HPF

  

 WBC

0–3/HPF

  

 Granular case

5–10/HPF

  
  1. ADAMTS13 a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13, BUN blood urea nitrogen, Hb hemoglobin, HPF high-power field, LDH lactate dehydrogenase, RBC red blood cells, WBC white blood cells